User Tools

Site Tools


meningococcal_prophylaxis

meningococcal chemoprophylaxis

introduction

  • contacts of patients with invasive meningococcal disease should be considered for contact tracing and chemoproprophylaxis.
  • in addition, there are vaccines but these do not cover all subtypes

indications for chemoprophylaxis

  • those who frequently ate, slept or stayed at the patient's home during the 7 days before the onset of symptoms, in particular, young children and their child caregivers or nursery-school contacts
  • those who sat beside the patient on an airplane flight of 8 hours or longer
  • those who had direct exposure to the patient through kissing, sharing utensils, drinking from same containers, etc
  • those who may have performed mouth-to-mouth resuscitation
  • doctors and nurses closely involved in intubation or other procedures involving patient's saliva or nasal secretions
  • patients who only received benzyl penicillin as this does not eradicate nasal carriage

chemoprophylaxis options

  • ceftriaxone 250 mg (child: 125 mg) IM, as a single dose (preferred option during pregnancy)
  • OR
  • ciprofloxacin (adult and child 12 years or more) 500 mg orally, as a single dose (preferred option for women taking oral contraceptives)
  • OR
  • rifampicin 600 mg (neonate: 5 mg/kg; child: 10 mg/kg up to 600 mg) orally, 12-hourly for 2 days (preferred option for children).
    • rifampicin is associated with multiple drug interactions, including the combined oral contraceptive pill (OCP), and is contraindicated in pregnancy, alcoholism and severe liver disease.
    • it will also stain contact lenses and cause the urine to go orange
meningococcal_prophylaxis.txt · Last modified: 2012/01/16 04:29 by 127.0.0.1

Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki